Cargando…
Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein
This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572355/ https://www.ncbi.nlm.nih.gov/pubmed/31130654 http://dx.doi.org/10.3390/molecules24102011 |
_version_ | 1783427621338480640 |
---|---|
author | Sun, Xiyang Xu, Xin Chen, Yanfei Guan, Rong Cheng, Tingting Wang, Ye Jin, Rui Song, Min Hang, Taijun |
author_facet | Sun, Xiyang Xu, Xin Chen, Yanfei Guan, Rong Cheng, Tingting Wang, Ye Jin, Rui Song, Min Hang, Taijun |
author_sort | Sun, Xiyang |
collection | PubMed |
description | This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in a murine Lewis lung carcinoma (LLC) model. LC-MS/MS results showed that the pharmacokinetic behaviors of a GEM active metabolite, gemcitabine triphosphate (dFdCTP), were found to be altered remarkably in the peripheral blood mononuclear cells (PBMC) of DBD co-administration rats. In addition, after co-administration of DBD with GEM, Western Blot and qPCR results confirmed that the expression of deoxycytidine kinase (dCK) in tumor tissues of LLC-bearing mice were markedly increased. DBD co-administration also reversed the upregulation of P-glycoprotein (P-gp) in tumor tissues induced by GEM. Moreover, DBD could notably up-regulate the IL-12p70 and GM-CSF expression in mice serum, suggesting potential immunomodulatory activities in tumor-bearing mice. Meanwhile, DBD inhibited the P-gp efflux activity in A549 cells. Therefore, the regulation of dCK and P-gp played important roles in the alternation of GEM pharmacokinetics and the enhancement of the anti-tumor effect of GEM. DBD being a potential dCK promoter could work as an adjuvant agent to boost the anticancer effect of GEM. |
format | Online Article Text |
id | pubmed-6572355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65723552019-06-18 Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein Sun, Xiyang Xu, Xin Chen, Yanfei Guan, Rong Cheng, Tingting Wang, Ye Jin, Rui Song, Min Hang, Taijun Molecules Article This study aimed to investigate whether the anti-tumor effect of gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) treatment was affected by Danggui Buxue decoction (DBD), and explore the potential mechanisms. The combined use of GEM and DBD showed an enhanced tumor growth inhibition effect in a murine Lewis lung carcinoma (LLC) model. LC-MS/MS results showed that the pharmacokinetic behaviors of a GEM active metabolite, gemcitabine triphosphate (dFdCTP), were found to be altered remarkably in the peripheral blood mononuclear cells (PBMC) of DBD co-administration rats. In addition, after co-administration of DBD with GEM, Western Blot and qPCR results confirmed that the expression of deoxycytidine kinase (dCK) in tumor tissues of LLC-bearing mice were markedly increased. DBD co-administration also reversed the upregulation of P-glycoprotein (P-gp) in tumor tissues induced by GEM. Moreover, DBD could notably up-regulate the IL-12p70 and GM-CSF expression in mice serum, suggesting potential immunomodulatory activities in tumor-bearing mice. Meanwhile, DBD inhibited the P-gp efflux activity in A549 cells. Therefore, the regulation of dCK and P-gp played important roles in the alternation of GEM pharmacokinetics and the enhancement of the anti-tumor effect of GEM. DBD being a potential dCK promoter could work as an adjuvant agent to boost the anticancer effect of GEM. MDPI 2019-05-25 /pmc/articles/PMC6572355/ /pubmed/31130654 http://dx.doi.org/10.3390/molecules24102011 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sun, Xiyang Xu, Xin Chen, Yanfei Guan, Rong Cheng, Tingting Wang, Ye Jin, Rui Song, Min Hang, Taijun Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title | Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title_full | Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title_fullStr | Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title_full_unstemmed | Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title_short | Danggui Buxue Decoction Sensitizes the Response of Non-Small-Cell Lung Cancer to Gemcitabine via Regulating Deoxycytidine Kinase and P-glycoprotein |
title_sort | danggui buxue decoction sensitizes the response of non-small-cell lung cancer to gemcitabine via regulating deoxycytidine kinase and p-glycoprotein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572355/ https://www.ncbi.nlm.nih.gov/pubmed/31130654 http://dx.doi.org/10.3390/molecules24102011 |
work_keys_str_mv | AT sunxiyang dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT xuxin dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT chenyanfei dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT guanrong dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT chengtingting dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT wangye dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT jinrui dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT songmin dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein AT hangtaijun dangguibuxuedecoctionsensitizestheresponseofnonsmallcelllungcancertogemcitabineviaregulatingdeoxycytidinekinaseandpglycoprotein |